Can You Sell Peptides on Amazon? What the Policy Says (2026)

Can you sell peptides on Amazon?

Amazon's drugs and drug paraphernalia policy, read on October 26, 2026, names 1 peptide class outright, listing "GLP-1 (Glucagon-like peptide-1) agonists" among the prescription drugs that cannot be sold, and it separately bars drug products that regulators identify as "misbranded, misleading, unapproved, recalled, or otherwise ineligible for sale" (Amazon). The policy describes no research use only category, and nothing on the page names a way to list products sold for laboratory research.

That is the short answer. The rest of this guide walks through the policy section by section, quotes each rule that touches a peptide catalog, sets those rules next to what FDA wrote to three peptide sellers in 2026, and ends with a checklist, a glossary and the full source list. Every quotation below was copied from a page captured on October 26, 2026.

Which Amazon policy covers peptides?

The page that governs this question is Amazon's Seller Central help article titled "Drugs and drug paraphernalia" (Amazon). It states at the top that it applies to selling in the United States, and it opens with a general duty: "If you list products on Amazon, you must comply with all applicable laws, regulations, standards, and our policies related to those products and product listings."

The policy then states its purpose. Amazon writes that "All product listings must comply with standards that prohibit unsafe, adulterated, controlled, and misleading drugs, as well as drug paraphernalia." It adds that "We also require specific packaging and labeling standards." Those two sentences frame everything that follows: the page is about which drug products may be listed at all, and about how the permitted ones must be packaged, labeled and documented.

How does Amazon define a drug?

Amazon's own definition turns on use rather than on chemistry. The policy describes a drug by what it is used for: it lists medical uses in people or animals, and it adds a substance used "or to change how the body works" (Amazon). It adds that "This includes prescription medications, over-the-counter drugs, and controlled substances."

The page defines three related terms. Controlled substances are "regulated or illegal drugs, such as narcotics, stimulants, or other restricted medications." Drug paraphernalia are "products primarily intended or designed for making, preparing, or using a controlled substance." Ingestible over the counter medications are products bought "without requiring a healthcare provider's prescription", and the page says they "come in various forms including tablets, gel capsules, powder, or liquid".

The policy does not define the word peptide, and the only time the word appears on the page is inside the GLP-1 entry quoted above. We checked the captured text for the phrases "research use" and "research chemical" and found neither.

What does Amazon's prohibited list say?

The section titled "Products that you can't sell under our policy" begins with a single sentence of principle: "We prohibit the listing or sale of unsafe, illegal, restricted, or prohibited products" (Amazon). The examples that follow are introduced with the words "Examples include, but are not limited to", so the list is not a complete catalog of what Amazon refuses.

Five parts of that list bear on a peptide brand. The table sets them out with the source of each row.

The first entry names the agencies whose findings count. Amazon lists "Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and Federal Trade Commission (FTC)" as examples of the regulatory bodies it means. That wording ties an Amazon listing decision to what those agencies have said about a product, which is why the FDA letters discussed later in this guide matter for a marketplace question.

Which other prohibited entries matter to a peptide catalog?

The prescription drug list sits next to entries that peptide sellers sometimes confuse with it. Amazon lists codeine, ephedrine and ergotamine as prescription drugs and active ingredients, and it lists "Fish antibiotics, both over-the-counter and prescription" and "Vaccines, both human and animal vaccines" in the same group (Amazon). GLP-1 agonists are the only peptide class the group names.

The unapproved drug list is longer. Besides the anabolic steroid entry, it names homeopathic teething products, kratom, phenylpropanolamine and "Loperamide products containing more than 48 mg". The list also carries Kanna with one asterisk and two herbs with two asterisks, and the footnotes for those marks are covered in the supplements section below.

The drug paraphernalia list names equipment rather than substances. It includes "Drug-purity testing kits", "Tableting and encapsulating machines", and "Tablet presses or molds that are used to press or imprint a pharmaceutical drug name or identification number onto a tablet or pill". It also lists "Pill-binding agents and excipient products". A brand that sells lab supplies alongside its catalog should read that list line by line, because Amazon groups these items as paraphernalia whether or not a drug is in the same order.

Does Amazon allow research use only products?

The policy page does not mention research use only products in any section. It offers no listing type, attribute, document or category for products sold with a label that limits them to research (Amazon). The only laboratory the page mentions is the testing lab Amazon requires for over the counter medicines, an "ISO 17025-accredited laboratory".

What the page does say is that a product's status can come from regulators. Its first prohibited example covers products that agencies identify as unapproved, and FDA's rules on intended use explain how FDA decides what a product is. Under 21 CFR 201.128, intended use means "the objective intent of the persons legally responsible for the labeling of an article (or their representatives)" (eCFR).

The same rule says that intent "may be shown by such persons' expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article." It adds that "This objective intent may, for example, be shown by labeling claims, advertising matter, or oral or written statements by such persons or their representatives." In other words, the rule looks at the whole picture around a product, not only the words printed on the vial.

Which words does Amazon's drug policy leave out?

We searched the captured text of the policy for the terms a peptide seller would look for. A zero means the term does not appear on the page as captured on October 26, 2026; it says nothing about any other Amazon page.

The page also sends readers elsewhere for the full prohibited list. It says "For more information about prohibited products, go to Restricted products" (Amazon). This guide covers the drugs and drug paraphernalia page only.

What did FDA write to peptide sellers in 2026?

FDA's Center for Drug Evaluation and Research posted three warning letters to peptide sellers that we captured on October 26, 2026. Each letter quoted the seller's own research labels and then explained why FDA did not treat those labels as settling the question. The table lists the label wording FDA quoted in each one.

In the Gram Peptides letter, FDA wrote that despite those statements, "evidence obtained from your website establishes that your products are intended to be drugs" (FDA). The two August letters use the same sentence in a footnote attached to the research label wording.

What evidence did FDA point to?

FDA did not rely on one statement. Each letter says that "Examples from your product labeling, including on your website, that provide evidence of the intended use (as defined in 21 CFR 201.128) of these products as drugs include, but may not be limited to, the following" and then quotes product page text at length (FDA). We do not repeat those quotations here, because they are health claims.

FDA also looked at what was sold together. In all three letters it wrote that "The sale of these products together demonstrates that you intend for your" companion liquid to be used with the peptides, and it treated that liquid as a drug too (FDA). In the NuScience letter FDA also noted that the firm offered a "peptide calculator" on its site (FDA).

That is the reach of 21 CFR 201.128 in practice. The rule names "the circumstances surrounding the distribution of the article" as evidence, and in these letters FDA counted the product pages, the items bundled on the same site and the tools offered next to them.

Which laws did FDA cite?

All three letters cite the same chain of provisions in the Federal Food, Drug, and Cosmetic Act. First, the products are called drugs under "section 201(g)(1) of the FD&C Act" (FDA). Second, they are called new drugs under section 201(p) because they are "not generally recognized as safe and effective (GRASE)" for the uses in their labeling.

Third, the letters explain the consequence. FDA wrote that "a new drug may not be introduced or delivered for introduction into interstate commerce without an approved application from FDA in effect", and that "No approved applications pursuant to section 505 of the FD&C Act, 21 U.S.C. 355, are in effect for these products." The letters conclude that the products are "unapproved new drugs", the same word Amazon uses in its first prohibited example.

The statute FDA cites is public. Section 201(p), codified at 21 U.S.C. 321(p), defines a new drug as one whose composition is such that it "is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs, as safe and effective" for the conditions in its labeling (Cornell LII, 21 U.S.C. 321).

What did FDA ask the sellers to do?

The letters set short deadlines. Gram Peptides was asked to respond "within fifteen working days of receipt of this letter" (FDA), and the two August recipients were asked to respond "within fifteen (15) business days of receipt of this letter" (FDA).

Each letter asks for "the specific steps you have taken to correct any violations" and for copies of related documentation. Each also warns of what follows a weak answer. The Gram Peptides letter says "Failure to adequately address this matter may lead to regulatory or legal action including, without limitation, seizure and injunction." The August letters close with a reminder: "Please note FDA posts warning letters on www.fda.gov."

For a marketplace seller, the posting point matters. Amazon's prohibited list keys on products that agencies have identified as unapproved, and FDA publishes its letters where anyone, including a marketplace reviewer, can read them.

How do the three FDA letters compare?

The letters share one structure but differ in timing and scope. Every cell in the table below was read from the letter it describes, captured on October 26, 2026.

Both August letters list products whose names begin with GLP-1. NuScience's list includes "GLP-1 Sema Research Peptide" (FDA), and Peptide Partners' list includes "GLP-1 S (Semaglutide)" (FDA). Amazon's prohibited list names the same three characters at the start of its entry for "GLP-1 (Glucagon-like peptide-1) agonists" (Amazon).

The letters and the policy do not refer to each other by name. None of the three letters mentions Amazon, and Amazon's policy page mentions no seller. The link between them is a general one: under "Additional resources", Amazon's page points sellers to FDA's warning letters page (Amazon).

When did each source say what it says?

Dates matter here because policy pages change and FDA posts new letters. The table puts every dated source in this guide in order.

A policy read on one date says nothing certain about the same page a month later. Re-read Amazon's page before you act on any rule quoted here.

What would Amazon require for a drug it does allow?

The page also describes what Amazon asks of drugs that may be sold, such as over the counter medicines. Amazon sets out a requirements table covering "Listing attributes", "Images", "Claims", "Offers", "Heightened compliance", "Documents" and "Third-party testing, inspection, and certification" (Amazon). Reading that table shows the documentation bar a drug listing must clear, even before the question of whether a product is allowed at all.

The listing attributes begin with "Item name: Name of the drug" and continue through brand name, manufacturer, active ingredients and shelf life. Amazon also asks for an "Appropriate cautionary statement", giving "Keep out of reach of children" as one example. The images must include a "Product identity statement" and the "Drug Facts panel (and any continued panels)".

What documents and testing does Amazon ask for?

For ingestible over the counter medicines, Amazon says "The information listed below applies only to ingestible over-the-counter medication." It requires sellers to work with "a direct product validation authorized third-party testing, inspection, and certification (TIC) service provider to verify all notified ASINs" (Amazon). Amazon adds that "You will no longer submit documents directly to Amazon. Instead, the TIC provider will submit them on your behalf."

The required documents are specific. Amazon asks for "Test reports from an ISO 17025-accredited laboratory" and a "Good Manufacturing Practices (cGMP) certificate from an ISO 17065-accredited certification body". The label images must show "The National Drug Code (NDC) number permanently affixed to both the product and its packaging".

Amazon also sets a pass rule for every document. The page says that "All testing documents provided to Amazon must show a result of either" a pass or a not applicable result. It adds that results showing a fail, not compliant or not met entry, or a blank result, "will not be accepted". It also requires that documents be "authentic, in their original, unmodified format, and not computer or AI-generated".

Which laws does Amazon say drug listings must meet?

The policy lists the laws, regulations and standards that drugs sold on Amazon must meet. The table below copies the drug rows, each from the same page (Amazon).

The same section adds a packaging rule: "Child-resistant closures and tamper-evident packaging must be present on applicable products as required by law." It also notes that Amazon "may limit who can buy certain products based on age, location, or both as required by local law."

What claims does Amazon forbid on drug listings?

The Claims rules apply to the listing attributes and the product images. Amazon says they must not "Include the FDA logo", and they must not claim FDA approval unless "the product has official FDA approval", which the page ties to an approved new drug application (NDA) or abbreviated new drug application (ANDA) (Amazon).

Two more rules close the list. Listings must not "Make claims that contradict or exceed the approved labeling for the product", and they must not "Make unverified claims." Amazon's example of an unverified claim is a product said to have the "effects of prescription medicines". The section ends with a pointer: "All claims must comply with our Misleading and prohibited claims policy."

Federal advertising law runs alongside these rules. Under 15 U.S.C. 52, "It shall be unlawful for any person, partnership, or corporation to disseminate, or cause to be disseminated, any false advertisement" for the purpose of inducing the purchase of food, drugs, devices, services or cosmetics (Cornell LII, 15 U.S.C. 52). Section 55 defines a false advertisement as one "which is misleading in a material respect" (Cornell LII, 15 U.S.C. 55).

The same section ties those rules to the FTC Act's ban on unfair practices. Section 52(b) says that spreading such an advertisement "shall be an unfair or deceptive act or practice in or affecting commerce within the meaning of section 45 of this title" (Cornell LII, 15 U.S.C. 52). Amazon's claims rules and this statute point at the same thing: what the listing says.

What does Amazon require of the offer itself?

The Offers rules are short. A drug offer must be "New: Sealed in the original manufacturer's packaging" and must be "The exact same product with no variation" (Amazon).

Amazon also requires the label and instructions to match the market. Among the conditions for submitted documents and images, the page lists that "Product instructions, manuals, safety information, labels, and warnings are in the language of the intended country of sale", and that "Images must show all sides of a product or its packaging". For bundles, Amazon asks sellers to "provide separate documents and images for each product included in the set or bundle".

How does Amazon enforce the policy?

Amazon describes enforcement in three places on the page. The first is testing. It warns that "Your products may be selected for periodic testing or inspection at any time", and that products "may also be randomly selected for surveillance testing through Amazon's safety program" (Amazon).

The second is deactivation. If a product fails testing or its documents fail review, Amazon says "the listing will be deactivated right away." The page adds that the listing "will stay deactivated until you send compliant documents to Amazon, and resolve all other issues for the ASIN."

The third is the general policy violations clause. Amazon writes that "Products that do not comply with this policy are subject to action." It reserves "the right to take any further actions in accordance with the Amazon Services Business Solutions Agreement, including, but not limited to, removing the relevant product listings." It also states: "We reserve the right to ask for additional information to verify product safety and compliance at any time."

Can you appeal an Amazon decision?

Yes, the page names one appeal route. Amazon writes: "If you believe that your product has been incorrectly classified as prohibited, submit an appeal on Account health" (Amazon).

The page describes a second route for the testing requirement. To start a request with a testing provider, or "to appeal the requirement", Amazon points sellers to its third party testing, inspection and certification services page.

An appeal argues that a product was put in the wrong category. The policy text gives no sign that an appeal changes the categories themselves, and the page offers no appeal path that converts a prohibited product into a permitted one.

Do the dietary supplement notes help?

Not for the entries that name peptides. The prohibited list ends with two footnotes. The first says "Products that comply with all applicable FDA regulations and Amazon's policy for Dietary supplements are permitted" (Amazon). On the page, that note is tied to the entries marked with one asterisk, and the only such entry is "Kanna".

The second footnote is tied to two entries marked with two asterisks, the single ingredient forms of damiana and marshmallow leaf. It says "Consumable products such as mixed herbal teas, tinctures, essential oils, and dietary supplements are permitted."

Neither mark appears next to the GLP-1 entry or the anabolic steroid entry. Amazon keeps a separate dietary supplements policy, which the page links under "Additional resources", and this guide does not cover that policy.

How does Amazon compare with eBay?

eBay's prescription and over the counter drugs policy, read the same day, also bars prescription products, using the words "Prescription drugs, or products containing prescription-strength medication, aren't allowed" (eBay). eBay's medical devices policy adds that "Needles, with or without a disposable syringe" are not permitted (eBay).

Our full walk through of eBay's rules is in can you sell peptides on eBay.

What should a peptide brand check before listing on Amazon?

These steps come from the policy text and the FDA rule quoted above. They describe what to read, not what any reader's result will be.

1. Find each product you sell on Amazon's prohibited list, including the GLP-1 entry and the anabolic steroid entry (Amazon).

2. Search FDA's posted warning letters for each compound you sell, since Amazon's first prohibited example keys on regulator findings.

3. Read your product pages, labels and bundles the way 21 CFR 201.128 describes: labeling claims, advertising matter and "the circumstances surrounding the distribution of the article" (eCFR).

4. Check every accessory you sell against Amazon's drug paraphernalia list.

5. Keep any written answer from Amazon Seller Support with your account records.

What should you ask Amazon Seller Support?

The policy leaves some questions for Amazon to answer about a specific product. These questions come straight from the rules quoted above; ask them in writing and keep the replies.

1. Which category does Amazon place each product in, and which help page governs it? The drug policy itself points to Restricted products for the full list (Amazon).

2. Does any product match an entry Amazon treats as identified by regulators, the group the policy calls "Drug products identified as misbranded, misleading, unapproved, recalled, or otherwise ineligible for sale by regulatory bodies"?

3. Does any accessory you plan to sell fall on the drug paraphernalia list, for example "Pill-binding agents and excipient products"?

4. If a product is permitted, which documents does the testing provider need, and which "ISO 17025-accredited laboratory" reports will Amazon accept?

5. If a listing is removed, is the right path an appeal for a product "incorrectly classified as prohibited", or a request to the testing provider?

A written answer from Amazon is the only source that settles how Amazon reads its own policy for your catalog.

Where do peptide brands sell instead?

Our guide to where you can sell peptides compares Shopify, WooCommerce, social platforms and marketplaces, and our comparison of peptide payment processors covers what each processor's terms say. For the card processing side of a store you run yourself, see does Square allow peptides.

FAQ

Does Amazon name any peptide in its drug policy? Yes, one class. Amazon lists "GLP-1 (Glucagon-like peptide-1) agonists" under prescription drugs and their active ingredients (Amazon).

Can a research use only label get a product onto Amazon? The policy does not mention research use only labels. It offers no category, attribute or document for them (Amazon).

Does FDA accept research labels as proof of intended use? In its 2026 letters to Gram Peptides, NuScience Peptides and Peptide Partners, FDA quoted the research labels and still wrote that "evidence obtained from your website establishes that your products are intended to be drugs" (FDA).

What happens if a listing breaks the policy? Amazon says such products "are subject to action", including "removing the relevant product listings" (Amazon).

Is there an appeal? Amazon tells sellers who believe a product "has been incorrectly classified as prohibited" to "submit an appeal on Account health" (Amazon).

Does the dietary supplement footnote cover peptides? On the page, that footnote is tied only to the entry marked with one asterisk, which is Kanna (Amazon).

Did FDA's 2026 letters name GLP-1 products? Both August 24, 2026 letters list products whose names begin with GLP-1, such as "GLP-1 S (Semaglutide)" in the Peptide Partners letter (FDA).

How long did FDA give the sellers to respond? Fifteen business days in the two August letters and fifteen working days in the Gram Peptides letter (FDA).

Which lab accreditation does Amazon name? For over the counter medicines, Amazon asks for "Test reports from an ISO 17025-accredited laboratory" (Amazon).

Is Amazon's policy page legal advice? No. Amazon's own disclaimer says "The information provided on this page does not and is not intended to constitute legal advice."

Glossary

Controlled substance. In Amazon's words, "regulated or illegal drugs, such as narcotics, stimulants, or other restricted medications" (Amazon).

Drug paraphernalia. Amazon's term for "products primarily intended or designed for making, preparing, or using a controlled substance."

Intended use. Under 21 CFR 201.128, "the objective intent of the persons legally responsible for the labeling of an article" (eCFR).

New drug. Under 21 U.S.C. 321(p), a drug "not generally recognized" by qualified experts as safe and effective for the conditions in its labeling (Cornell LII).

False advertisement. Under 15 U.S.C. 55, an advertisement, other than labeling, "which is misleading in a material respect" (Cornell LII).

GRASE. FDA's short form for "generally recognized as safe and effective", the test a drug must meet to avoid being a new drug (FDA).

cGMP. Current good manufacturing practice; Amazon asks for a "Good Manufacturing Practices (cGMP) certificate from an ISO 17065-accredited certification body" (Amazon).

TIC provider. The "third-party testing, inspection, and certification (TIC) service provider" Amazon requires for over the counter medicines.

NDC. The National Drug Code, which Amazon requires to be "permanently affixed to both the product and its packaging".

Key facts

• Amazon prohibits "the listing or sale of unsafe, illegal, restricted, or prohibited products" (Amazon).
• Amazon lists "GLP-1 (Glucagon-like peptide-1) agonists" among prohibited prescription drugs (Amazon).
• Amazon's drug policy describes no research use only category (Amazon).
• Amazon says a listing that fails testing or document review "will be deactivated right away" (Amazon).
• FDA's 2026 letters to 3 peptide sellers each say "evidence obtained from your website establishes that your products are intended to be drugs" (FDA).
• 21 CFR 201.128 says intended use may be shown by "labeling claims, advertising matter, or oral or written statements" (eCFR).

This guide covers marketplace policy for business owners and gives no medical guidance. It is not legal advice; for your own business, ask a lawyer who handles FDA and marketplace matters.

Sources

• Amazon Seller Central: Drugs and drug paraphernalia
• eCFR: 21 CFR 201.128
• Cornell LII: 21 U.S.C. 321
• Cornell LII: 15 U.S.C. 52
• Cornell LII: 15 U.S.C. 55
• FDA: warning letter to Gram Peptides, March 31, 2026
• FDA: warning letter to NuScience Peptides LLC, August 24, 2026
• FDA: warning letter to Peptide Partners LLC, August 24, 2026
• eBay: Prescription and over-the-counter drugs policy
• eBay: Medical devices and equipment policy

Sources checked October 26, 2026.